Global Tumor Ablation Market Forecast and Regional Analysis 2023

For Report Sample Contact: neeraj@kuickresearch.com

 

Report Weblink: https://www.kuickresearch.com/report-global-tumor-ablation-market-forecast-and-regional-analysis-2023.php

 

Table of Contents

 

1. Tumor Ablation andndash; A Minimally Invasive Cancer Therapeutic

  1.1 Prologue to Tumor Ablation Therapy

  1.2 History and Progress of Tumor Ablation Therapy

2. Demand and Features of the Tumor Ablation Therapy

  2.1 Dire Need for a Safe and Non-Invasive Cancer Therapy

  2.2 Compelling Features of the Tumor Ablation Therapy

3. Tumor Ablation andndash; Providing an Edge over Existing Cancer Therapeutics

  3.1 Direct Tumoricidal Effect

  3.2 Minimal Invasive Therapy

  3.3 Affordability

  3.4 Applicable to a Non-surgical Candidate

  3.5 Swift Procedure With Faster Recovery

  3.6 Can be Repeated Multiple Times

4. Technological Aspect of Tumor Ablation Therapy

5. Radiofrequency Ablation Therapy

  5.1 Overview

  5.2 Therapeutic Mechanism of Radiofrequency Ablation

6. Microwave Tumor Ablation Therapy

  6.1 The Physics of Microwave and its Therapeutic Mechanism

  6.2 Superiority of Microwave Ablation Therapy Compared to Radiofrequency

       Ablation Therapy

7. Cryoablation Therapy

  7.1 Cryoablation Therapy andndash; An Emerging Modern Cancer Ablation Procedure

  7.2 Procedure, Mechanism and Clinical Applications of Cryoablation Therapy

8. High Intensity Focused Ultrasound (HIFU)

  8.1 An Insight into the Progress of HIFU over the Last Decade

  8.2 Working Mechanism of High Intensity Focused Ultrasound

9. Other Tumor Ablation Therapeutics

  9.1 Laser Induced Thermal Therapy for Tumor Ablation

  9.2 Irreversible Electroporation Ablation (IER)

10. Tumor Ablation Types by Mode of Treatment

  10.1 Surgical Ablation of Tumors

  10.2 Laparoscopic Tumor Ablation

  10.3 Percutaneous Tumor Ablation

11. Technology, Devices and Tools Involved in Tumor Ablation Therapy

  11.1 Imaging Technologies

    11.1.1 Computed Tomography

    11.1.2 Magnetic Resonance Imaging (MRI)

  11.2 Catheters or Probes

12. Clinical Status of Tumor Ablation Therapy in Various Cancer Types

  12.1 Primary Hepatocellular Carcinoma (HCC)

  12.2 Non-Small Cell Lung Cancer

  12.3 Renal (Kidney Tumor Ablation)

  12.4 Prostate Cancer

  12.5 Breast Cancer

  12.6 Bone Metastasis

  12.7 Pancreas

13. Recent Advances in Tumor Ablation Therapy

14. Exploring the Commercial Aspects of Tumor Ablation Therapy

  14.1 Cost Benefit Analysis of Tumor Ablation Therapy

  14.2 Tumor Ablation Cost Analysis

    14.2.1 Common Cost of Tumor Lesion Treatment Using any of the Available

            Ablation Modalities

    14.2.2 Modality Specific Ablation Cost for a 3cm Kidney Lesion

15. Global Tumor Ablation Therapy Market Current Scenario

  15.1 Tumor Ablation Market by Technology

  15.2 Tumor Ablation Therapy Market by Mode of Treatment

  15.3 Tumor Ablation Market by Application

16. Tumor Ablation Therapy Market by Region

  16.1 North America

  16.2 Europe

  16.3 Asia Pacific

  16.4 Rest of the World

17. Global Tumor Ablation Therapy Market Dynamics

  17.1 Driving Factors of the Tumor Ablation Market

  17.2 Restraining Factors in the Growth of Tumor Ablation Therapy Market

18. Anticipation Regarding the Future of Tumor Ablation Therapy Market

19. Competitive Landscape

  19.1 Angiodynamics

  19.2 Boston Scientific

  19.3 Galil Medicals

  19.4 INTIO Inc.

  19.5 Medtronic Inc.

  19.6 Misonix Inc.

  19.7 NeuWave Medical Inc.

  19.8 SonaCare Medical

  19.9 Medwaves

  19.10 BSD Medicals

  19.11 ProstaLund

  19.12 Halyard Health

 

Figure 1-1: Evolution of Tumor Ablation Therapy

Figure 2-1: Desired Characteristic of an Ideal Ablation Therapy

Figure 3-1: Superiority of Tumor Ablation over Other Cancer Therapeutics

Figure 4-1: Tumor Ablation Technology Types

Figure 5-1: Thermal Destruction of Tumor using RFA

Figure 5-2: Radiofrequency Ablation Therapy Clinical Setup

Figure 6-1: Principle of Microwave Ablation

Figure 6-2: Advantages of Microwave Ablation over Radiofrequency Ablation

Figure 7-1: Increasing the Efficacy of Cryoablation by Nanoparticle-Encapsulated Doxorubicin (n-DOX)

Figure 8-1: High Intensity Focused Ultrasound in Action

Figure 9-1: Irreversible Electroporation Ablation in Action

Figure 10-1: Tumor Ablation Types by Mode of Treatment

Figure 11-1: Imaging Technologies Used in Tumor Ablation

Figure 11-2: Various Types of Probes Used in Tumor Ablation

Figure 12-1: Radiofrequency Ablation in Treatment of Liver Tumor

Figure 12-2: Cryoablation Therapy for Renal Cancer

Figure 14-1: Cost of Various Ablation Therapeutics (US$), 2016

Figure 15-1: Global – Tumor Ablation Market Segmentation

Figure 15-2: Global – Increase in the Number of Geriatric Population (Billion), 1990-2050

Figure 15-3: Global – Tumor Ablation Therapy Market by Region (%), 2016

Figure 15-4: Global – Tumors Ablation Modalities Market Share (%), 2016

Figure 15-5: Global – Radiofrequency Ablation Device Market (US$ Million), 2015-2023

Figure 15-6: Global – Microwave Ablation Therapy Device Market (US$ Million), 2015-2023

Figure 15-7: Global andndash; Cryoablation Therapy Device Market (US$ Million), 2015-2023

Figure 15-8: Global – Tumor Ablation Market by Treatment Modality (%), 2016

Figure 15-9: Number of Patients Undergoing Tumor Ablation Therapy (‘000), 2016

Figure 16-1: North America andndash; Tumor Ablation Therapy Market (US$ Million), 2015-2023

Figure 16-2: North America – Radiofrequency Ablation Device Market (US$ Million), 2015-2023

Figure 16-3: North America – Microwave Ablation Therapy Device Market (US$ Million), 2015-2023

Figure 16-4: North America – Cryoablation Therapy Device Market (US$ Million), 2015-2023

Figure 16-5: North America – Tumor Ablation Therapy by Mode of Treatment, 2016

Figure 16-6: Europe – Tumor Ablation Therapy Market (US$ Million), 2015-2023

Figure 16-7: Europe- Regional Tumor Ablation Therapy Market Share (%), 2016

Figure 16-8: Europe – Tumor Ablation Therapy by Mode of Treatment (%), 2016

Figure 16-9: Asia – Tumor Ablation Therapy by Treatment (%), 2016

Figure 16-10: Asia -Tumor Ablation Therapy Market (US$ Million), 2015-2023

Figure 16-11: Rest of the world- Tumor Ablation Therapy Market (US$ Million), 2015-2023

Figure 17-1: Global – Driving Factors of the Tumor Ablation Therapy Market

Figure 17-2: Cancer – Global Prevalence (‘000), 2015

Figure 17-3: Global – Challenging Factors of the Tumor Ablation Therapy

Figure 18-1: Global – Future Aspects of Tumor Ablation Therapy

Table 14-1: Tumor Ablation Cost by Modalities (2016)

Table 14-2: Tumor Ablation Cost for Kidney Lesion